Suppr超能文献

Mixed vascular occlusion in a patient with interferon-associated retinopathy.

作者信息

Bajaire Boris J, Paipilla Diego F, Arrieta Cesar E, Oudovitchenko Elena

机构信息

Department of Vitreous and Retina, San Martin University, Bogota, Colombia.

出版信息

Case Rep Ophthalmol. 2011 Jan 11;2(1):23-9. doi: 10.1159/000323942.

Abstract

Interferon (INF)-associated retinopathy occurs in 15-64% of INF-treated patients, transforming this complication into a significant risk for visual impairment. This retinopathy has been described as an ocular complication with a variable clinical course, usually benign and asymptomatic. The most common findings are hemorrhages and cotton wool spots. Atypical ocular side effects include branch or central retinal artery occlusion, central retinal vein occlusion, anterior ischemic optic neuropathy, optic disc edema, neovascular glaucoma and vitreous hemorrhage. Some case series suggest that in most cases the clinical course of the disease is benign, asymptomatic and without long-term consequences and therefore do not recommend any specific treatment; they only recommend the discontinuation of INF in patients with severe manifestations or risk factors such as hypertension or diabetes mellitus. The case reported here presents an atypical manifestation of INF-associated retinopathy consisting of a mixed retinal vascular occlusion (arterial and venous), associated with severe occlusive inflammatory microangiopathy with extensive retinal damage by ischemia and a torpid clinical course despite suspension of treatment. These varieties of occlusive vascular events have not yet been found simultaneously in the literature and neither with an unfavorable clinical course. Although the clinical course of INF-associated retinopathy in most cases is asymptomatic, there may be complications with risk to vision, which is less common. The magnitude and severity of the consequences associated with INF therapy are to be determined in prospective further studies.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2f3/3037983/96fb7e394dd1/cop0002-0023-f01.jpg

相似文献

1
Mixed vascular occlusion in a patient with interferon-associated retinopathy.
Case Rep Ophthalmol. 2011 Jan 11;2(1):23-9. doi: 10.1159/000323942.
3
Branch retinal artery occlusion as an initial ocular manifestation of severe iron deficiency anemia: A rare case report.
Taiwan J Ophthalmol. 2021 Jan 7;12(2):227-230. doi: 10.4103/tjo.tjo_70_20. eCollection 2022 Apr-Jun.
5
Prevalent misconceptions about acute retinal vascular occlusive disorders.
Prog Retin Eye Res. 2005 Jul;24(4):493-519. doi: 10.1016/j.preteyeres.2004.12.001.
9
Venous stasis retinopathy in a ten-year-old boy with ocular hypertension: a case report.
BMC Ophthalmol. 2020 Oct 27;20(1):428. doi: 10.1186/s12886-020-01662-z.
10
Hyperbaric oxygen therapy and the eye.
Undersea Hyperb Med. 2008 Sep-Oct;35(5):333-87.

引用本文的文献

2
Combined Branch Retinal Artery and Central Retinal Vein Occlusion: A Systematic Review.
Vision (Basel). 2023 Jul 28;7(3):51. doi: 10.3390/vision7030051.
3
Targeted Cancer Therapy and Its Ophthalmic Side Effects: A Review.
J Immunother Precis Oncol. 2021 Feb 25;4(1):6-15. doi: 10.36401/JIPO-20-21. eCollection 2021 Feb.
4
Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations.
Graefes Arch Clin Exp Ophthalmol. 2019 Mar;257(3):447-452. doi: 10.1007/s00417-018-04209-7. Epub 2018 Dec 13.
5
Tolerability and efficacy of pegylated consensus interferon-α in the treatment of chronic hepatitis C.
Exp Ther Med. 2017 Jan;13(1):9-16. doi: 10.3892/etm.2016.3914. Epub 2016 Nov 18.
6
Interferon-gamma (IFN-γ)-mediated retinal ganglion cell death in human tyrosinase T cell receptor transgenic mouse.
PLoS One. 2014 Feb 28;9(2):e89392. doi: 10.1371/journal.pone.0089392. eCollection 2014.
7
Ophthalmologic complications of antiviral therapy in hepatitis C treatment.
World J Gastroenterol. 2013 Dec 7;19(45):8227-37. doi: 10.3748/wjg.v19.i45.8227.

本文引用的文献

1
INTERFERON-β-ASSOCIATED RETINOPATHY.
Retin Cases Brief Rep. 2009 Winter;3(1):24-6. doi: 10.1097/ICB.0b013e31814b160d.
2
Vitreous hemorrhage associated with interferon-a therapy for chronic hepatitis C.
Retin Cases Brief Rep. 2008 Fall;2(4):262-3. doi: 10.1097/ICB.0b013e3181238457.
3
Bevacizumab (Avastin) for the treatment of ocular disease.
Surv Ophthalmol. 2009 May-Jun;54(3):372-400. doi: 10.1016/j.survophthal.2009.02.004.
4
Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C.
World J Gastroenterol. 2007 Jun 14;13(22):3137-40. doi: 10.3748/wjg.v13.i22.3137.
5
Interferon-associated retinopathy--a case report.
Klin Monbl Augenheilkd. 2007 Apr;224(4):350-2. doi: 10.1055/s-2007-962837.
8
[Interferon causes ischemic ocular diseases--case studies and review of the literature].
Klin Monbl Augenheilkd. 2006 May;223(5):367-71. doi: 10.1055/s-2006-926593.
9
[Interferon alpha-associated retinopathy in patients with chronic hepatitis C].
Klin Monbl Augenheilkd. 2005 Nov;222(11):915-8. doi: 10.1055/s-2005-858842.
10
Is screening for interferon retinopathy in hepatitis C justified?
Br J Ophthalmol. 2004 Dec;88(12):1518-20. doi: 10.1136/bjo.2004.043968.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验